Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02240329Phase 1Completed
Phase 1, open-label, single-arm trial, sponsored by University of Florida. Primary endpoints: Average Urge to Cough at Day 1 and Number of Coughs at Day 1. Started Mar 2013; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02240329.